Verwandte Artikel zu Levodopa and Carbidopa Controlled Release Matrix Tablets:...

Levodopa and Carbidopa Controlled Release Matrix Tablets: Formulation and InVitro Evaluation - Softcover

 
9783838348117: Levodopa and Carbidopa Controlled Release Matrix Tablets: Formulation and InVitro Evaluation

Inhaltsangabe

In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Reseña del editor

In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

EUR 13,78 für den Versand von Vereinigtes Königreich nach USA

Versandziele, Kosten & Dauer

Suchergebnisse für Levodopa and Carbidopa Controlled Release Matrix Tablets:...

Beispielbild für diese ISBN

Somagoni, Jagan Mohan; Madhusudan Rao, Y.; Kishan, V.
ISBN 10: 3838348117 ISBN 13: 9783838348117
Neu Softcover

Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Zustand: New. In. Artikel-Nr. ria9783838348117_new

Verkäufer kontaktieren

Neu kaufen

EUR 45,57
Währung umrechnen
Versand: EUR 13,78
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

Anzahl: Mehr als 20 verfügbar

In den Warenkorb

Beispielbild für diese ISBN

Somagoni, Jagan Mohan; Madhusudan Rao, Y.; Kishan, V.; Somagoni, Jagan Mohan; Madhusudan Rao, Y.; Kishan, V.
ISBN 10: 3838348117 ISBN 13: 9783838348117
Neu Paperback

Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Paperback. Zustand: Brand New. 72 pages. 8.50x5.80x0.30 inches. In Stock. Artikel-Nr. x-3838348117

Verkäufer kontaktieren

Neu kaufen

EUR 64,47
Währung umrechnen
Versand: EUR 11,50
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

Anzahl: 2 verfügbar

In den Warenkorb

Foto des Verkäufers

Jagan Mohan Somagoni
ISBN 10: 3838348117 ISBN 13: 9783838348117
Neu Taschenbuch

Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Taschenbuch. Zustand: Neu. Neuware -In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not.Books on Demand GmbH, Überseering 33, 22297 Hamburg 72 pp. Englisch. Artikel-Nr. 9783838348117

Verkäufer kontaktieren

Neu kaufen

EUR 49,00
Währung umrechnen
Versand: EUR 60,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer

Anzahl: 2 verfügbar

In den Warenkorb